A 2000 Patient Retrospective Assessment of a New Strategy for Burn Wound Management in View of Infection Prevention and Treatment

Overview

Journal Int Wound J

Specialties Emergency Medicine
Orthopedics

Date 2017 Dec 16

PMID 29243368

Citations 8

Authors

Justyna Glik

Wojciech Labus

Diana Kitala

Karolina Mikus-Zagorska

Christopher D Roberts

Mariusz Nowak

Aleksandra Kasperczyk

Marek Kawecki

Affiliations

Soon will be listed here.

Abstract

Infections in burn patients are still the principal cause of complications in burn injuries. The aim of this study is to assess a new strategy for burn wound management in view of infection prevention and treatment in the experience of the Burn Treatment Center in Siemianowice Śląskie. The applied methodology involved the analysis of patient records describing the hospital's epidemiological situation between 2014 and 2016. The analysis also included the use and cost of antibiotics, silver-containing dressings, and other antiseptics relative to the number of sepsis cases, including those caused by Pseudomonas aeruginosa, as well as the mortality ratio. The total costs of prevention and treatment of infections were reduced, while the use of silver-containing dressings and antiseptics increased. The number of patients with sepsis decreased, including cases caused by P. aeruginosa, and the mortality ratio was reduced. Introducing a strategy for burn wound-oriented infection prevention and treatment in burn patients provides a number of benefits. It is also cost-effective. Using locally applied active dressings and antiseptics can be a welcome choice for often-unnecessary antibiotic therapy of a suspected or existing burn wound infection.

Citing Articles

Blood Stream Infections in Burns: A 14-Year Cohort Analysis.

Nitsani Y, Michael T, Halpern D, Hasidim A, Sher M, Givoli Vilensky R Life (Basel). 2023; 13(6).

PMID: 37374139 PMC: 10304160. DOI: 10.3390/life13061357.

An enhanced fractal self-pumping dressing with continuous drainage for accelerated burn wound healing.

Lan J, Shi L, Xiao W, Zhang X, Wang Y, Wang S Front Bioeng Biotechnol. 2023; 11:1188782.

PMID: 37082216 PMC: 10110875. DOI: 10.3389/fbioe.2023.1188782.

Circular RNA expression profiles following negative pressure wound therapy in burn wounds with experimental infection.

Yang Y, Liu M, Yang F, Wang X, Bai X, Mu S Bioengineered. 2021; 13(2):4122-4136.

PMID: 34898366 PMC: 8973835. DOI: 10.1080/21655979.2021.2006965.

A retrospective review of the use of a nanocrystalline silver dressing in the management of open chronic wounds in the community.

Hurd T, Woodmansey E, Watkins H Int Wound J. 2021; 18(6):753-762.

PMID: 33660375 PMC: 8613393. DOI: 10.1111/iwj.13576.

Viral Infections in Burn Patients: A State-Of-The-Art Review.

Baj J, Korona-Glowniak I, Buszewicz G, Forma A, Sitarz M, Teresinski G Viruses. 2020; 12(11).

PMID: 33213058 PMC: 7698518. DOI: 10.3390/v12111315.

References

Dunn K, Edwards-Jones V . The role of Acticoat with nanocrystalline silver in the management of burns. Burns. 2004; 30 Suppl 1:S1-9. DOI: 10.1016/s0305-4179(04)90000-9. View

Saaiq M, Ahmad S, Zaib M . Burn wound infections and antibiotic susceptibility patterns at pakistan institute of medical sciences, islamabad, pakistan. World J Plast Surg. 2015; 4(1):9-15. PMC: 4298859. View

Erol S, Altoparlak U, Akcay M, Celebi F, Parlak M . Changes of microbial flora and wound colonization in burned patients. Burns. 2004; 30(4):357-61. DOI: 10.1016/j.burns.2003.12.013. View

Macedo J, Santos J . Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz. 2005; 100(5):535-9. DOI: 10.1590/s0074-02762005000500014. View

Fong J, Wood F . Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2007; 1(4):441-9. PMC: 2676636. DOI: 10.2147/nano.2006.1.4.441. View

Percival S, McCarty S, Lipsky B . Biofilms and Wounds: An Overview of the Evidence. Adv Wound Care (New Rochelle). 2015; 4(7):373-381. PMC: 4486148. DOI: 10.1089/wound.2014.0557. View

Thomas S, McCubbin P . A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care. 2003; 12(3):101-7. DOI: 10.12968/jowc.2003.12.3.26477. View

Elliott T, Lambert P . Antibacterial resistance in the intensive care unit: mechanisms and management. Br Med Bull. 2000; 55(1):259-76. DOI: 10.1258/0007142991902240. View

Bahmani N, Ramazanzadeh R . Detection of SHV type Extended-Spectrum B-lactamase and Risk Factors in Pseudomonas aeruginosa Clinical Isolates. Pak J Med Sci. 2013; 29(3):788-92. PMC: 3809287. DOI: 10.12669/pjms.293.3263. View

10.

Roberts C, Leaper D, Assadian O . The Role of Topical Antiseptic Agents Within Antimicrobial Stewardship Strategies for Prevention and Treatment of Surgical Site and Chronic Open Wound Infection. Adv Wound Care (New Rochelle). 2017; 6(2):63-71. PMC: 5286547. DOI: 10.1089/wound.2016.0701. View

11.

Wright J, Lam K, Buret A, Olson M, Burrell R . Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002; 10(3):141-51. DOI: 10.1046/j.1524-475x.2002.10308.x. View

12.

Lawrence J, Soothill J . Burn wound infection. Burns. 1989; 15(5):342. DOI: 10.1016/0305-4179(89)90016-8. View

13.

Namias N, Samiian L, Nino D, Shirazi E, ONeill K, Kett D . Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma. 2000; 49(4):638-45; discussion 645-6. DOI: 10.1097/00005373-200010000-00010. View

14.

Schwacha M, Holland L, Chaudry I, Messina J . Genetic variability in the immune-inflammatory response after major burn injury. Shock. 2005; 23(2):123-8. DOI: 10.1097/01.shk.0000148073.19717.a9. View

15.

Tredget E, Shankowsky H, Groeneveld A, Burrell R . A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998; 19(6):531-7. DOI: 10.1097/00004630-199811000-00013. View

16.

Atiyeh B, Gunn S, Hayek S . State of the art in burn treatment. World J Surg. 2005; 29(2):131-48. DOI: 10.1007/s00268-004-1082-2. View

17.

Reid G . Biofilms in infectious disease and on medical devices. Int J Antimicrob Agents. 1999; 11(3-4):223-6; discussion 237-9. DOI: 10.1016/s0924-8579(99)00020-5. View

18.

Ayan M, Durmaz R, Aktas E, Durmaz B . Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J Hosp Infect. 2003; 54(1):39-45. DOI: 10.1016/s0195-6701(03)00076-8. View

19.

Levin A . Treatment of Acinetobacter spp infections. Expert Opin Pharmacother. 2003; 4(8):1289-96. DOI: 10.1517/14656566.4.8.1289. View

20.

Glik J, Kawecki M, Gazdzik T, Nowak M . The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis. Pol Przegl Chir. 2012; 84(1):6-16. DOI: 10.2478/v10035-012-0002-7. View